TrialSignal
Clinical trial intelligence report
Effect of Perioperative Roxadustat in Elective Lumbar Interbody Fusion Surgery: a Parallel-group, Open-label, Randomised Controlled Trial.
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jun 20, 2026
NCT ID
NCT06772272
Status
ACTIVE_NOT_RECRUITING
Phase
PHASE3
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Executive brief
Investment-Ready Snapshot
This clinical trial investigates the efficacy and safety of Roxadustat in reducing perioperative blood transfusions in patients with anemia undergoing elective lumbar interbody fusion surgery. The study aims to provide insights into the potential market for Roxadustat in surgical settings, particularly for patients with anemia, which is a significant concern in surgical outcomes.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT06772272
Indication
Perioperative Anemia
Modality
small molecule
Target
Perioperative Anemia
Intervention
Roxadustat
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.